Comparison of E-Learning and Face-to-Face Learning in Cardiopulmonary Exercise Test Training
Launched by KAYSERI CITY HOSPITAL · Mar 18, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to compare two different ways of teaching doctors about a special test called the Cardiopulmonary Exercise Test (CPET), which helps evaluate how well the heart and lungs work during exercise. The study will see if learning through online lessons (e-learning) is as effective as traditional in-person classes (face-to-face) for doctors in training.
To participate in this trial, doctors must be graduates from a medical school and currently in specialized training. They also need to be able to attend the training sessions and complete the required tasks, like participating in live classes and answering questions. Unfortunately, if someone cannot regularly attend the classes, especially if they miss more than four without a valid reason, they will not be able to take part in the study. Overall, this trial will help determine the best way to teach an important test that can impact patient care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Those who gave consent,
- • Graduates of the Faculty of Medicine and currently receiving specialist training,
- • Those who can do what the training requires during the training period (participating in live classes, answering scales, etc.)
- Exclusion Criteria:
- • Those who cannot attend the training program regularly
- • In addition, those who cannot attend more than 4 classes with or without an excuse will be excluded from the study.
About Kayseri City Hospital
Kayseri City Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor of clinical studies, the hospital combines state-of-the-art facilities with a multidisciplinary team of experienced healthcare professionals. Committed to enhancing therapeutic options and contributing to the scientific community, Kayseri City Hospital focuses on rigorous research protocols and ethical standards to ensure the safety and efficacy of new treatments. Through collaboration with academic institutions and industry partners, the hospital plays a vital role in translating research findings into practical applications that benefit patients and the broader healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
HAVVA TALAY ÇALIŞ
Study Director
Health Sciences University, Kayseri Medical Faculty
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported